(Q40986509)

English

Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer

scientific article published on May 1995

Statements

Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer (English)
M J Kennedy
D K Armstrong
A M Huelskamp
K Ohly
B V Clarke
O M Colvin
L B Grochow
T L Chen
N E Davidson
1 May 1995
1136-1143

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit